Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
•
Neuro-critical care
What is your threshold for initiating tocilizumab in patients with NORSE?
Related Questions
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
How do you decide on the treatment target of burst suppression pattern vs seizure cessation for patients with status epilepticus?
How do you transition from Levetiracetam to Brivaracetam, particularly at doses of 1500 mg BID or higher?
Would you use bupropion for mood disorder or substance use in an adult patient with previous childhood seizures that resolved?
How do you approach treatment of vasospasm after AVM rupture?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
When do you consider pacing in arrhythmogenic epilepsy?
Which factors help you choose between intermittent phenobarbital dosing versus continuous pentobarbital infusion for pharmacological burst suppression in refractory status epilepticus?
How do you utilize at-home seizure monitoring devices for your patients with epilepsy?
When do you usually introduce conversations regarding tracheostomy placement in patients with refractory status epilepticus, or other conditions where one may anticipate delayed awakening?
